We can’t show the full text here under this license.
Using CRISPR gene editing in stomach cancer: how it works, recent progress, and treatment possibilities
Updated
Abstract
CRISPR/Cas9 technology may significantly enhance understanding and treatment of gastric cancer.
- CRISPR/Cas9 is being used to identify oncogenes and tumor suppressors associated with gastric cancer.
- Modeling interactions within the tumor microenvironment is facilitated by CRISPR/Cas9 applications.
- Recent advances in genome editing have improved knowledge of gastric cancer development and resistance to treatments.
- Therapeutic gene editing using CRISPR/Cas9 faces challenges, including off-target effects and delivery methods.
- Ethical considerations are an important aspect of implementing CRISPR/Cas9 in gastric cancer therapy.
Simplified